09-12-2020 17:05
Public concerns have ignited over the recall of a popular anti-allergy drug produced by BRV Healthcare, a joint venture between domestic group BV Pharma and UK firm RV Group.
22-10-2020 09:00
Violations in the pharmaceutical industry are seemingly never-ending, with Young Il Pharm, USV Private, and Armepharco being among recent prominent names. However, future wrongdoings may be better resisted when new stricter rules come into effect next month.
13-08-2020 08:00
Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
17-07-2020 14:00
The Ministry of Health has made advancements in regulations to facilitate multinational pharmaceutical corporations and to make them align with the EU-Vietnam Free Trade Agreement. However, some concerns remain. Nitin Kapoor, vice chairman of Pharma Group under the EuroCham in Vietnam, talked with VIR’s Bich Thuy what impact the changes had on its members, and their preparations to benefit from the promising chances after the transition.
23-07-2020 14:00
Despite strict requirements, international pharma giants like Novartis, AstraZeneca, and Pfizer are rushing to complete all necessary procedures to receive the most sought-after GMP recognition for their manufacturing sites, signalling a hotter tender market in the months to come.
18-06-2020 09:00
With SK Group recently joining the mergers and acquisitions race, Vietnam’s pharma and healthcare market is becoming more robust. However, newcomers are expected to face challenges amid increasingly mounting competition in the lucrative pharmaceutical market in the months to come, driven by the enforcement of the EU-Vietnam Free Trade Agreement.
02-04-2020 08:00
Despite having risk management solutions to ensure drug import continuity to Vietnam in response to EU border closures, international pharma giants Sanofi, Zuellig Pharma, Adamed, and Novartis are closely monitoring the situation due to the potential direct impacts on long-term supply security.
12-09-2019 14:00
Facing much tougher competition ahead, Vietnamese big pharmaceutical firms are seeking new solutions in order to delve deeper into the ethical drugs channel to shore up growth. However, creating and implementing such solutions will not be smooth sailing. Bich Thuy reports.
30-06-2019 22:00
In anticipation of the long-awaited landmark EU-Vietnam Free Trade Agreement, the lucrative Vietnamese pharmaceutical market is expected to open up wider to European businesses, heralding new investment inflows from the continent in the months to come. Bich Thuy reports.
04-10-2018 10:00
After years of takeover fears, more of Vietnam’s leading pharmaceutical firms now ponder a historic change of heart by scrapping foreign ownership limits with a view to the international market, then opening vast distribution business opportunities for new players. Bich Thuy reports.
24-05-2018 10:58
The Ministry of Health is sounding the war horn for a charge against distribution of pharmaceuticals under the cover of providing preserving services by some foreign-invested enterprises, with leading Asian healthcare services provider Zuellig Pharma Vietnam being the prime suspect.
11-03-2018 09:00
Recording excellent performances in 2017, Vietnam’s pharmaceutical giants have set high profit expectations for 2018 despite stiffening competition in the market.
02-11-2017 08:00
Vietnam’s pharmaceutical market continues to be a lucrative industry, evidenced by the huge profits reaped by leading drug makers in this year’s first nine months, despite increasingly fierce competition from foreign rivals.
04-07-2017 10:07
Lack of a master plan has been blamed for Việt Nam having to import up to 80 per cent of its processed pharmaceutical materials although the country has an abundant source of pharmaceutical materials and was one of top exporters of raw pharmaceutical materials in the 1980s.
04-07-2016 10:26
Vietnam has been urged to improve intellectual property protection and the business climate in an effort to encourage foreign direct investment inflows to the healthcare sector.